IRIS
DI STASI, SAVINO MAURO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 57.349
EU - Europa 5.782
AS - Asia 5.409
SA - Sud America 963
Continente sconosciuto - Info sul continente non disponibili 392
AF - Africa 84
OC - Oceania 19
Totale 69.998
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 57.041
SG - Singapore 2.502
IT - Italia 1.460
CN - Cina 964
UA - Ucraina 814
BR - Brasile 759
FR - Francia 729
DE - Germania 671
RU - Federazione Russa 577
HK - Hong Kong 552
IE - Irlanda 485
VN - Vietnam 429
FI - Finlandia 270
GB - Regno Unito 246
KR - Corea 229
SE - Svezia 214
BD - Bangladesh 171
CA - Canada 160
JP - Giappone 153
PL - Polonia 88
IN - India 80
ID - Indonesia 79
AR - Argentina 66
NL - Olanda 62
MX - Messico 50
CL - Cile 41
IQ - Iraq 34
ES - Italia 33
TR - Turchia 30
EC - Ecuador 28
ZA - Sudafrica 27
PK - Pakistan 25
JM - Giamaica 24
VE - Venezuela 20
AT - Austria 19
CO - Colombia 16
EG - Egitto 16
IL - Israele 16
MY - Malesia 16
PY - Paraguay 16
CR - Costa Rica 15
LT - Lituania 15
AE - Emirati Arabi Uniti 14
AU - Australia 14
CZ - Repubblica Ceca 14
MA - Marocco 14
EU - Europa 13
HU - Ungheria 13
DK - Danimarca 12
PH - Filippine 12
GR - Grecia 11
TW - Taiwan 11
UZ - Uzbekistan 11
SA - Arabia Saudita 10
TH - Thailandia 10
KG - Kirghizistan 9
NI - Nicaragua 9
TT - Trinidad e Tobago 9
CH - Svizzera 8
HN - Honduras 8
IR - Iran 8
NP - Nepal 8
BB - Barbados 7
AL - Albania 6
BE - Belgio 6
DZ - Algeria 6
PE - Perù 6
SV - El Salvador 6
TN - Tunisia 6
KE - Kenya 5
KW - Kuwait 5
PR - Porto Rico 5
RO - Romania 5
UY - Uruguay 5
AZ - Azerbaigian 4
EE - Estonia 4
JO - Giordania 4
KZ - Kazakistan 4
PT - Portogallo 4
BG - Bulgaria 3
BO - Bolivia 3
GE - Georgia 3
GP - Guadalupe 3
GT - Guatemala 3
KH - Cambogia 3
NG - Nigeria 3
OM - Oman 3
PS - Palestinian Territory 3
BH - Bahrain 2
DO - Repubblica Dominicana 2
GY - Guiana 2
HR - Croazia 2
HT - Haiti 2
LB - Libano 2
NR - Nauru 2
NZ - Nuova Zelanda 2
PA - Panama 2
SI - Slovenia 2
SM - San Marino 2
SN - Senegal 2
Totale 69.599
Salva come PNG Salva come JPEG
Città #
Woodbridge 16.343
Wilmington 14.933
Houston 12.684
Ashburn 1.815
Singapore 1.380
Fairfield 1.221
San Jose 805
Ann Arbor 730
Jacksonville 716
Hong Kong 536
Seattle 480
Dublin 479
Chandler 463
Council Bluffs 412
Cambridge 400
Medford 372
Beijing 344
Santa Clara 288
Dearborn 239
Rome 194
Lawrence 174
New York 172
Los Angeles 169
The Dalles 139
Dallas 137
Lauterbourg 118
Helsinki 117
Buffalo 116
Moscow 113
Mülheim 113
Ho Chi Minh City 111
Tokyo 108
São Paulo 99
Milan 91
Hanoi 84
Phoenix 82
Menlo Park 76
Kraków 65
San Diego 62
Chicago 57
Jakarta 56
Dong Ket 53
Atlanta 50
University Park 50
Toronto 49
London 43
Seongnam 41
Springfield 41
Zhengzhou 41
North Bergen 39
Brooklyn 38
Nuremberg 38
Boardman 37
Columbus 34
Montreal 32
Munich 32
Falls Church 31
Frankfurt am Main 30
Denver 27
Naples 27
Rio de Janeiro 26
Bologna 25
Redondo Beach 25
San Francisco 25
Guangzhou 24
Seoul 23
Shanghai 21
Hefei 20
Orem 20
Curitiba 19
Florence 19
Nanjing 19
Tampa 19
Verona 19
Norwalk 18
Redwood City 18
Da Nang 17
Chennai 16
Haiphong 16
Temuco 15
Washington 15
Amsterdam 14
Johannesburg 14
Kunming 14
Salvador 14
Stockholm 14
Turin 14
Belo Horizonte 13
Catania 13
Mexico City 13
Warsaw 13
Boston 12
Buenos Aires 12
Hangzhou 12
Jinan 12
Kingston 12
Kyiv 12
Vilnius 12
Baghdad 11
Campinas 11
Totale 58.487
Salva come PNG Salva come JPEG
Nome #
Measurement of the thickness of the urethrovaginal space in women with or without vaginal orgasm 895
L’ecocolor Doppler nella diagnosi di prostatite granulomatosa especifica: esperienza personale. 598
An individual patient data meta-analysis of the long-term outcome of randomised studies comparing intravesical mitomycin C versus bacillus calmette-guerin for non-muscle-invasive bladder cancer 587
New Frontiers in Intravesical Therapies and Drug Delivery 581
Cisti intraparenchimali del didimo: aspetti ecografici. 579
Botulinum-A toxin injections into the detrusor muscle decrease nerve growth factor bladder tissue levels in patients with neurogenic detrusor overactivity 555
Updates in intravesical electromotive drug administration(A (R)) of mitomycin-C for non-muscle invasive bladder cancer 553
Concordance and clinical significance of uncommon variants of bladder urothelial carcinoma in transurethral resection and radical cystectomy specimens 522
La cistite emorragica da ciclofosfamide: nostra esperienza su 79 pazienti sottoposti a trapianto di midollo osseo 513
Hexaminolevulinate hydrochloride in the detection of nonmuscle invasive cancer of the bladder 509
The Nocturnal alarm as a conditioning therapy in primary nocturnal enuresis. 508
Prevalence of chronic prostatitis in men with premature ejaculation. 506
Metastasis-free survival is a strong Surrogate of overall survival in localized prostate cancer 503
L'Ecografia nella diagnosi dei diverticoli dell'uretra femminile. 498
A prospective, randomized study using transdermal electromotive administration of verapamil and dexamethasone for Peyronie's disease. 497
Intravesical electromotive administration of oxybutynin in patients with detrusor hyperreflexia unresponsive to standard anticholinergic regimens 491
Intravesical capsaicin versus resiniferatoxin in patients with detrusor hyperreflexia: a prospective randomized study. 488
Concentration-depth profiles of mitomycin-C in the human bladder wall after passive diffusion, thermochemotherapy, and electromotive drug administration. 488
Botulinum A toxin intravesical injections in the treatment of painful bladder syndrome: A pilot study 485
Intravesical electromotive mitomycin C versus passive transport mitomycin C for high risk superficial bladder cancer: a prospective randomized study. 485
Sequential BCG and electromotive mitomycin versus BCG alone for high-risk superficial bladder cancer: A randomised controlled trial 482
Type V phosphodiesterase inhibitor treatments for erectile dysfunction increase testosterone levels. 481
Intravesical resiniferatoxin versus botulinum-A toxin injections for neurogenic detrusor overactivity: a prospective randomized study. 477
Tissue pharmacokinetics of mitomycin-c in the human bladder wall after passive diffusion, thermo-chemotherapy and electromotive drug administration. 474
La cistite emorragica da ciclofosfamide: nostra esperienza su 79 pazienti sottoposti a trapianto di midollo osseo. 473
Pelvic floor muscle behavior during Valsalva leak point pressure measurement in males and females affected by stress urinary incontinence. 471
Prognostic factors and risk groups in T1G3 non-muscle-invasive bladder cancer patients initially treated with Bacillus Calmette-Guérin: results of a retrospective multicenter study of 2451 patients. 469
The efficacy of BCG TICE and BCG Connaught in a cohort of 2,099 patients with T1G3 non–muscle-invasive bladder cancer 465
Are referral centers for non-muscle-invasive bladder cancer compliant to EAU guidelines? A report from the vesical antiblastic therapy Italian study. 463
Electromotive delivery of mitomycin C into human bladder wall 463
Retropubic, laparoscopic, and robot-assisted radical prostatectomy: surgical, oncological, and functional outcomes: a systematic review. 462
The transcription factor FBI-1 inhibits SAM68-mediated BCL-X alternative splicing and apoptosis. 462
Intermittent catheterization with a prelubricated catheter in spinal cord injured patients: A prospective randomized crossover study 461
Electromotive instillation of mitomycin immediately before transurethral resection for patients with primary urothelial non-muscle invasive bladder cancer: a randomised controlled trial. 461
Transdermal electromotive administration of verapamil and dexamethasone for Peyronie's disease 458
Cavernous hemangioma of the renal hilum presenting as an avascularized solid mass 455
The human bladder urothelium: new concepts and future perspectives. 455
La terapia intralesionale dei tumori superficiali a cellule transizionali della vescica con interferone alfa ricombinante 455
Single preoperative intravesical instillation of electromotive mitomycin-c for primary non-muscle invasive bladder cancer: a prospective randomized trial. 455
Lower urinary tract dysfunction and disability status in patients with multiple sclerosis 454
Ontogenetic profile and thyroid hormone regulation of type-1 and type-8 glucose transporters in rat Sertoli cells. 454
Electromotive administration of oxybutynin into the human bladder wall. 452
The efficacy and safety of duloxetine in a multidrug regimen for chronic prostatitis/chronic pelvic pain syndrome. 451
Alfa-2a-interferon in neoadjuvant and adjuvant therapy of superficial ladder cancer: preliminary results. 449
Adjuvant alpha-interferon in renal cell carcinoma at high risk of relapse. A multicentre pilot study. 449
Intravesical adjuvant electromotive drug administration (EMDA®) of mitomycin-C in patients with intermediate-risk non-muscle invasive bladder cancer: A randomized controlled trial 445
Electromotive delivery of mitomycin C into human bladder wall 442
Electromotive versus passive diffusion of mitomycin C into human bladder wall: concentration-depth profiles studies 442
The bladder urothelium: passive permeabilità and intravesical drug passive diffusion. 440
Diuretic ultrasound. A non-invasive technique for the assessment of upper tract obstruction. 439
Intravesical electromotive drug administration. 438
Valsalva leak point pressure 437
Urodynamic assessment of bladder and urethral sphincter function before radical prostatectomy and during long-term follow-up. 436
Contemporary management of non-muscle invasive bladder cancer at italian referral centres adopting eau guidelines 436
Intravesical electro-osmotic administration of mitomycin C 436
Quality of life after radical prostatectomy or external beam radiotherapy for localized prostate cancer: a controlled prospective study. 435
Platelet-derived growth factor regulation of type-5 phosphodiesterase in human and rat penile smooth muscle cells. 434
The impact of re-transurethral resection on clinical outcomes in a large multicentre cohort of patients with T1 high-grade/Grade 3 bladder cancer treated with bacille Calmette–Guérin 434
Successful management of retroperitoneal malignant fibrous histiocytoma involving both kidneys 433
A prospective, randomized study using transdermal electromotive administration of verapamil and dexamethasone for Peyronie's disease 433
Gender identity rather than sexual orientation impacts on facial preferences. 433
Intralesional alpha interferon therapy in papillary superficial transitional cell carcinoma of the bladder. A pilot study. 430
Extraction and determination of oxybutynin in human bladder samples by reversed-phase high-performance liquid chromatography. 430
Intravesical electromotive administration of oxybutynin: from laboratoty to clinica field. 429
Clean intermittent catheterization and prevention of renal disease in spinal cord injury patients 429
Single immediate preoperative intravesical instillation of electromotive mitomycin-C for low risk superficial bladder cancer: A prospective randomized study. 429
Successful management of retroperitoneal malignant fibrous histiocytoma involving both kidneys. 421
Clean intermittent catheterization and prevention of renal disease in spinal cord injury patients. 419
Defibrotide versus eparina calcica nella profilassi della trombosi venosa profonda in chirurgia urologica: studio randomizzato. 419
Diverticoli uretrali ed ascessi parauretrali nella donna: nostra esperienza. 419
Intralesional alpha interferon therapy in papillary superficial transitional cell carcinoma of the bladder. A pilot study 418
Tumori vescicali intradiverticolari. Diagnosi preoperatoria. 418
Transdermal electromotive administration of verapamil and dexametasone for Peyronie’s disease 418
Celecoxib for the prevention of nonmuscle invasive bladder cancer: Results from a matched control study 418
Lower urinary tract dysfunction and disability status in patients with multiple sclerosis 416
Our experience with Epirubicin in the treatmnet of superficial bladder tumors after conservative therapy. 415
Intravesical sequential BCG and electromotive mitomycin versus BCG alone for stage pT1 urothelial bladder cancer 415
Intravesical sequential BCG and electromotive mitomycin versus BCG alone in high risk non-muscle invasive bladder cancer 413
Prognostic Factors And Risk Groups In T1g3 Patients Initially Treated With Bcg: Results Of A Multicenter Retrospective Series In 2530 Patients 413
BCG nel carcinoma vescicale 411
Intravesical electromotive drug administration of mitomycin-C for non-muscle invasive bladder cancer 410
Il ruolo dell'ecografia nello studio delle neoplasie della via escretrice superiore 410
Percutaneous sequential bacillus Calmette-Guérin and mitomycin C for panurothelial carcinomatosis. 409
Le flogosi prostatiche: ruolo dell'ecografia nella diagnosi. 409
Autonomic dysreflexia during urodynamics 408
Il drenaggio percutaneo ecoguidato transperineale delle raccolte pelviche 408
Malattia di La Peyronie. 407
BCG nel carcinoma vescicale 406
Color Doppler echography in the diagnosis of nonspecific granulomatous prostatis: personal experience. 405
Electromotive instillation of mitomycin immediately before transurethral resection for patients with primary urothelial non-muscle invasive bladder cancer: a randomised controlled trial 404
Percutaneous sequential bacillus Calmette-Guèrin and mitomycin C for panurothelial carcinomatosis 403
Cavernous hemangioma of the renal hilum presenting as an avascularized solid mass. 403
Intravesical baobab oil in the management of bcg-induced lower urinary tract symptoms 403
Intravesical sequential bacillus Calmette-Guérin and electromotive mitomycin versus bacillus Calmette-Guérin alone for stage pt1 urothelial bladder cancer 400
Diuretic ultrasound. A non-invasive technique for the assessment of upper tract obstruction 397
The stability and electromotive administration of resiniferatoxin into the pig bladder wall 396
Neoplasia prostatica: rapporto tra evoluzione locale e sistemica. 395
Intravesical oxybutynin: mode of action assessed by passive diffusion and electromotive administration with pharmacokinetics of oxybutynin and N-desethyl oxybutynin. 394
Single preoperative intravesical instillation of electromotive anitomycin-C for primary non-muscle-invasive bladder cancer: A prospective randonsied trial 394
Incontinenza Urinaria nell’Uomo Anziano. 393
Totale 45.419
Salva come PNG Salva come JPEG
Categoria #
all - tutte 147.362
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 147.362
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.251 0 0 0 120 62 91 86 76 93 122 78 523
2022/20231.715 211 104 47 155 123 426 172 96 113 40 175 53
2023/2024782 70 41 83 47 51 93 90 46 43 45 22 151
2024/20254.080 163 993 454 191 80 346 207 132 258 313 506 437
2025/20266.471 503 261 837 404 535 311 844 675 709 735 384 273
2026/20273.273 359 366 1.211 1.337 0 0 0 0 0 0 0 0
Totale 69.998